Single-dose vaccine testing in children; Johnson and Johnson seeking permission

by National | 20-08-2021 | 578 views

New Delhi: The American pharma company Johnson Johnson has moved an application to the Central Drugs Standard Control Organisation (CDSCO) seeking permission to conduct a study of COVID-19 single shot vaccine in India in adolescents aged 12 17 years.

Earlier on August 7, the Drugs Controller General of India approved the emergency use of this single-dose vaccine in adults. However, not even a single dose of the Johnson & Johnson vaccine has been administered so far amid an impasse over issues such as indemnity which has not been granted to either Serum Institute of India or Bharat Biotech. Notably, the Centre has already constituted a team to engage with vaccine makers Pfizer, Moderna and Johnson & Johnson for a speedy resolution.

"India expands its vaccine basket! Johnson and Johnsons single-dose COVID-19 vaccine is given approval for Emergency Use in India. Now India has 5 EUA vaccines. This will further boost our nation's collective fight against," Mansukh Mandaviya said.

The vaccine maker has claimed that its single-shot Covid-19 vaccine has shown promising signs of protection against the Delta variant rapidly spreading across the US and other countries.

Lets socialize : Share via Whatsapp